Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Other Non-Current Liabilities (2024 - 2025)

BioAge Labs (BIOA) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $370000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 137.18% to $370000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $370000.0 through Dec 2025, up 137.18% year-over-year, with the annual reading at $370000.0 for FY2025, 137.18% up from the prior year.
  • Other Non-Current Liabilities hit $370000.0 in Q4 2025 for BioAge Labs, up from $150000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $613000.0 in Q3 2024 to a low of $97000.0 in Q1 2025.